ABSTRACT
Objective To investigate the management of Graves' disease in Jiangsu province. Methods According to the 2011 management of GD survey from American Thyroid Association and the 2013 survey from European Thyroid Association, a questionnaire was designed for this survey to acquire the diagnosis, treatment, and follow-up of Graves' disease among endocrinologists from 35 tertiary hospitals in Jiangsu province. Results A total of 476 valid questionnaires were collected. For patients with symptoms of hyperthyroidism, a large majority of respondents monitored serum FT3 , FT4 , TSH, thyroid peroxidase antibody, thyroglobulin antibody, TSH receptor antibody, and finding of thyroid ultrasound, accounted for 95. 6％, 95. 0％, 95. 4％, 95. 8％, 90. 3％, 90. 5％, and 93. 9％physicians, respectively. 91.2％ of physicians preferred anti-thyroid drugs as the first-line treatment, and 92. 6％ of them gave priority to the use of methimazole. For the duration of anti-thyroid drugs therapy, 41.2％of endocrinologists chose 24 months, while 20％ chose 18 months. When patients have moderate and active ophthalmopathy, most respondents with medium or senior professional titles preferred anti-thyroid drugs, while most resident physicians chose radioactive iodine plus corticosteroids. When pregnancy was confirmed in the patients of Graves' disease, 88％ of respondents preferred propylthiouracil during the first trimester of pregnancy, and 58. 4％ of them would continue propylthiouracil into the second trimester. Conclusions The mastering of basic perception of Graves' disease knowledge is satisfactory among the endocrinologists. But by comparing to the American and European survey results and related guidelines, there are still some differences in diagnosis and treatment. Therefore, physicians should notice those differences and make improvement on standardized treatment for patients to raise the response ratio while reducing the recurrent events.
ABSTRACT
Objective To analyze the amount and allocation of pediatric healthcare resources in Chengdu,and to recommend on local pediatric healthcare resources shortages.Methods Pediatric healthcare resources data of Chengdu came from pediatric relevant data reported regularly at yearend by the counties and districts to healthcare administration of the city.Data from such reports were subject to statistics with various indexes and descriptive analysis.Analyzed in focus was the distribution in 2015 of pediatric healthcare resources of the city among medical institutions of various types,levels and properties,as well as causes for such shortage.Results Tertiary hospitals hold 62.3% of the pediatric beds and 64.2% of pediatricians,and provide around 70% of the medical workload for pediatric outpatients and inpatients,upon the majority of pediatricians with master degree and above,and senior ones of/above associate chief physician titles;Tertiary hospitals have 58.7% of the pediatric beds and 49.7% of pediatricians,yet the outpatients served by specialized hospitals were 5% above tertiary hospitals.Conclusions The imbalance and shortage in total of pediatric resources in Chengdu result from stable source of manpower supply,high professional risk exposure,low income,and long training duration among others.Such measures as a better pediatrician development system,greater incentives for pediatric development,and enhanced development pediatric service consortiums,as well as greater support for private specialized pediatric hospitals.Those measures combined can effectively alleviate the shortage of pediatric resources.
ABSTRACT
The current status of the domestic manufacturing and sales markets of Anoectochilus roxburghii were investigated and analyzed in the study. Some problems in the A. roxburghii industry were revealed and a variety of sustainable development countermeasures were also proposed. The main problems of A. roxburghii industry are the lack of protection for wild resources, the lag in the speed of variety breeding, the insufficient research on the quality systems, the low level of industry and product innovation capability, as well as the relatively low market cognition and brand competence. Therefore, strengthening the protection for breeding resources, establishing a dynamic monitoring system, promoting the variety breeding, constructing a propagation system for improved varieties, enhancing the quality of medicinal herbs, accelerating the adjustment of product structure, upgrading the industry technology, strengthening brand competence and expanding the market, will be the effective methods to realize the sustainable development of A. roxburghii industry.
ABSTRACT
The paper analyzed the development and main problems of medical records management in hospitals,and proposed a number of measures based on the ongoing healthcare reform for medical records management in the hospitals.These include targeted management; innovative management model to enhance service; enhanced information security for better protection of patient privacy and hospital's intangible assets; modern management theories and technologies for resolving remaining problems in medical records management; scientific building of medical records quality control system.On such basis,the paper discussed the development trend and strategy of hospital medical records management.
ABSTRACT
Clinical practice guidelines are systematically developed clinical multi-discipline advisory statements which assist providers, recipients and other stakeholders to make informed decisions about appropriate health interventions. Chinese government and some clinical academic communities began to develop the domestic guidelines after 2000. Nevertheless, there were still some shortcomings presented in the domestic guidelines if assessed by the advanced appraisal instrument of the developed countries. There were four aspects as follow. The first, misunderstood the guidelines are the rule or text book. The second, ignored presentation of the procedure about development of guidelines. The third, there were a lack of high level evidences. The fourth, not declared editorial independence. However, it is necessary to develop the domestic guideline of China. With rising conflicts between the increasing needs for health care and shortage of our environment resource, development of the guidelines become one of the key steps in the process of clinical practice.
ABSTRACT
OBJECTIVE:To provide the reference for Chinese pharmaceutical industry in order to satisfy the global phar-maceutical market.METHODS:The development and manufacture of new drugs in today's world market were analyzed in the respect of advancement of technology,medical fee,drug consumption,transferring of research and development center,as well as the development of multinational enterprises.RESULT&CONCLUSION:Great importance should be attached to the development and manufacture of new drugs in today's world market in order to promote the development of Chinese phar-maceutical industry.
ABSTRACT
At present,medicinal plant extract industry in China develops rapidly.As a modern industry,it does not only use the traditional Chinese medicinal materials as raw materials in conception and content,but also use medicinal plant extract as a core,including worldwide medicinal plant extract.China is an important country of extract production in the world.The present status accompanied with the existed questions and induced factors,countermeasure for development,and suggestion for medicinal plant extract industry in China are discussed in this article.It lays the emphasis on present status of industry for medicinal plant extract which involves the production,application,technology,standard and policy of present status influenced on development stage of plant extract enterprise itself in domestic and international.The development countermeasure and suggestion are put forward from seven aspects.
ABSTRACT
This paper describes the present status and existing problems of clinically monitoring blood drug concentrations, in hospital pharmacy in Shanxi Province. The ways to solve these problems are suggested.
ABSTRACT
This paper analyses the present status of production and marketing as well as the existing problems about antipyretic analgesics at home and abroad. It presents the description on the recently developed products and new preparations. The trend of development in the future is anticipated as well.
ABSTRACT
This paper summarizes the main achievements and the existing problems of clinical pharmacy in China since establishing the discipline. The cause which accounts for the occurrence of these problems is briefly analysed. On the basis, we suggest the way to develope clinical pharmacy in the future. The following three topics are discussed in detail:establishing related rules and regulations, trainning qualified personnel, and encouraging pharmaceutists to contact clinical work.
ABSTRACT
This paper stresses the importance of establishing an monitoring system for adverse reactions of drugs, and describes the present status in China. The main points in future work are put forward.
ABSTRACT
The status and progress in research of anti-AIDS agents at home and abroad are reviewed, some suggestions have been made for further steps in this research work.